SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 29th, 2024 • Tonix Pharmaceuticals Holding Corp. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 28, 2024, between Tonix Pharmaceuticals Holding Corp., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
TONIX PHARMACEUTICALS HOLDING CORP. 8-KPlacement Agency Agreement • March 29th, 2024 • Tonix Pharmaceuticals Holding Corp. • Pharmaceutical preparations • New York
Subject to the terms and conditions of this letter agreement (the “Agreement”) between A.G.P./Alliance Global Partners (the “Placement Agent”), as sole placement agent, and Tonix Pharmaceuticals Holding Corp., a Nevada corporation (the “Company”), the parties hereby agree that the Placement Agent shall serve as the placement agent for the Company, in connection with the proposed registered direct offering (the “Placement”) of securities of the Company, consisting of: (i) shares of common stock, par value $0.001 per share (“Common Stock”), (ii) pre-funded warrants to purchase Common Stock (the “Pre-Funded Warrants”), and (iii) Series E warrants to purchase Common Stock (the “Common Warrants” and collectively with the Pre-Funded Warrants, the “Warrants”). The Common Stock and Warrants actually sold by the Placement Agent are referred to herein as the “Placement Agent Securities.” The Placement Agent Securities and shares of Common Stock issuable upon the exercise of the Warrants shall be
AMENDMENT TO THE COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant Amendment • March 29th, 2024 • Tonix Pharmaceuticals Holding Corp. • Pharmaceutical preparations
The Amendment to the Common Stock Purchase Warrant (this “Amendment”) is entered into as of April 1, 2024, by and between Tonix Pharmaceuticals Holding Corp., a Nevada corporation (the “Company”), and [ ] (the “Holder”). Terms not defined herein shall have the meaning ascribed to them in that certain Securities Purchase Agreement dated March 28, 2024, by and between the Company and the Purchasers identified therein.
